Damora Therapeutics, Inc. (DMRA)
24.87
+0.12
(+0.48%)
USD |
NASDAQ |
Sep 16, 09:34
Damora Therapeutics Price : 24.87 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 28.00 | 28.16 | 24.14 | 24.75 | 1.678M |
| Sep 14, 2026 | 28.42 | 29.18 | 28.00 | 28.39 | 372084.0 |
| Sep 11, 2026 | 27.32 | 28.53 | 26.87 | 28.10 | 525411.0 |
| Sep 10, 2026 | 25.87 | 27.78 | 25.63 | 26.84 | 639788.0 |
| Sep 09, 2026 | 28.77 | 29.29 | 26.26 | 26.27 | 500073.0 |
| Sep 08, 2026 | 29.66 | 30.74 | 28.89 | 29.17 | 559967.0 |
| Sep 04, 2026 | 27.49 | 30.35 | 27.39 | 30.06 | 295833.0 |
| Sep 03, 2026 | 28.52 | 28.60 | 27.40 | 28.00 | 328157.0 |
| Sep 02, 2026 | 28.36 | 29.38 | 27.82 | 28.18 | 462946.0 |
| Sep 01, 2026 | 28.10 | 28.45 | 27.12 | 28.14 | 272798.0 |
| Aug 31, 2026 | 28.93 | 28.93 | 26.52 | 28.18 | 497024.0 |
| Aug 28, 2026 | 30.38 | 30.71 | 28.42 | 29.00 | 371725.0 |
| Aug 27, 2026 | 30.18 | 31.11 | 29.87 | 30.60 | 171253.0 |
| Aug 26, 2026 | 30.48 | 30.88 | 30.10 | 30.39 | 185908.0 |
| Aug 25, 2026 | 30.55 | 31.64 | 30.54 | 30.62 | 205710.0 |
| Aug 24, 2026 | 30.67 | 31.49 | 29.70 | 30.31 | 319818.0 |
| Aug 21, 2026 | 30.45 | 31.38 | 30.14 | 30.82 | 159911.0 |
| Aug 20, 2026 | 31.84 | 32.07 | 30.12 | 30.31 | 226536.0 |
| Aug 19, 2026 | 32.43 | 33.56 | 31.41 | 32.44 | 486698.0 |
| Aug 18, 2026 | 30.74 | 32.17 | 30.29 | 31.80 | 485659.0 |
| Aug 17, 2026 | 31.10 | 31.79 | 30.81 | 31.09 | 362726.0 |
| Aug 14, 2026 | 30.37 | 31.52 | 29.50 | 31.04 | 260656.0 |
| Aug 13, 2026 | 31.13 | 31.13 | 30.16 | 30.73 | 227791.0 |
| Aug 12, 2026 | 30.29 | 31.55 | 29.89 | 31.00 | 314351.0 |
| Aug 11, 2026 | 29.89 | 30.78 | 29.14 | 30.36 | 234884.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 26.80 |
| Alnylam Pharmaceuticals, Inc. | 236.39 |
| Anika Therapeutics, Inc. | 20.91 |
| Savara, Inc. | 5.30 |
| Vericel Corp. | 39.23 |
Price Related Metrics
| PEG Ratio | -0.0002 |
| Price to Book Value | 3.978 |
| Earnings Yield | -501.7% |
| Market Cap | 1.536B |
| PEGY Ratio | -0.0002 |